ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
2024Äê9ÔÂ23ÈÕÖÁ25ÈÕ£¬×ðÁú¿Ê±½«×÷Ϊа쵥룬¼ÓÈëÓɹú¼ÊÎïÀí»¯Ñ§¼ÒлᣨIAPC£©ºÍADMET&DMPK¹ú¼ÊÆÚ¿¯ÁªºÏÖ÷ÀíµÄ¡°µÚ¾Å½ì¹ú¼ÊÒ©ÎïÑо¿ÓëÉú³¤ÐÂÐËÊÖÒÕ´ó»á£¨IAPC-9£©¡±¡£
×ðÁú¿Ê±Ê×ϯ¿ÆÑ§¹ÙÅíË«Çå½ÌÊÚÊÜÑûµ£µ±´ó»á¿ÆÑ§×éί»áίԱ£¬²¢³öϯ´ó»á¡£
ͬʱ£¬×ðÁú¿Ê±¶¾ÀíÑо¿²¿¸±×ܲÃ&ÄÏ»ãsite»ú¹¹ÈÏÕæÈËÔøÏܳɲ©Ê¿Ò²½«³öϯ´ó»á£¬²¢ÔÚ¡°Session 7¡ªToxicology/Safety/Drugability assessments¡±·Ö»áÖе£µ±ÁªºÏÖ÷ϯ£»Ê±´ú£¬Ôø²©Ê¿»¹½«·ÖÏí¡°Safety assessment of preclinical candidates - An analysis and comparison of NOAEL/MTD and safety windows between rodents and non-rodents¡±¡£
×ðÁú¿Ê±ÍŶӽ«È«³ÌÔÚL2չλÆÚ´ýÄúµÄݰÁÙ½»Á÷¡£
»áÔ°µØÍ¼
ÔøÏÜ³É ²©Ê¿ ×ðÁú¿Ê±¶¾ÀíÑо¿²¿¸±×ܲá¢ÄÏ»ãsite»ú¹¹ÈÏÕæÈË
¸ß¼¶¹¤³Ìʦ£¬2010ÄêÔÚÉϺ£Ò½Ò©¹¤ÒµÑо¿Ôº»ñµÃҽѧ²©Ê¿Ñ§Î»£¬2010-2013ÄêÔÚ¹ú¼ÒÉϺ£ÐÂÒ©Çå¾²ÆÀ¼ÛÑо¿ÖÐÐÄÊÂÇ飬ÔÚ´Ëʱ´ú±»ÅÉÍù¹ú¼ÒʳÎïÒ©Æ·¼àÊÓÖÎÀí×ܾÖÒ©Æ·ÉóÆÀÖÐÐľÙÐÐÐÂÒ©ÉóÆÀÀíÂÛºÍÊÖÒÕÅàѵºÍʵ¼ù£»2013Äê¼ÓÈë×ðÁú¿Ê±ÆÕÑÇÒ½Ò©¿Æ¼¼£¨ÉϺ££©ÓÐÏÞ¹«Ë¾£¬ÏÖÈζ¾ÀíÑо¿²¿¸±×ܲ㬴ÓÊÂÉúÎïÊÖÒÕÒ©Îï¡¢ÒßÃç¼°»¯Ñ§Ò©Æ·Ò»Ñùƽ³£¶¾ÐÔÊÔÑéÑо¿²¢¼ç¸º¶¾ÀíÑо¿²¿ÍŶÓÖÎÀíÊÂÇé¡£×÷ΪÏîÄ¿ÈÏÕæÈËÍê³ÉÁË20¸ö1À໯ҩ¡¢8¸ö¿¹ÌåżÁªÒ©Îï¡¢10¸öµ¥¿Ë¡¿¹Ìå¡¢2¸ö¼¤ËØÒ©Îï¡¢2¸öÔ¤·ÀÓÃÒßÃç¼°1¸ö¸´·½Ò©ÎïÉ걨ÖйúºÍ/»òÃÀ¹úÕûÌ×µÄÒ»Ñùƽ³£¶¾ÐÔºÍÒ©´ú¶¯Á¦Ñ§Ñо¿¡£×÷Ϊ¿ÎÌâÈÏÕæÈ˼縺ÁËÉϺ£ÊпÆÎ¯×ÊÖúµÄʵÑ鶯ÎïרÏîÑо¿2Ï×÷Ϊ×Ó¿ÎÌâÈÏÕæÈ˼ÓÈëÁË¡°Ê®Ò»Î塱¹ú¼ÒÐÂÒ©´´ÔìÖØ´óרÏîÑо¿¡£
·ÖÏíÖ÷Ì⣺Safety assessment of preclinical candidates - An analysis and comparison of NOAEL/MTD and safety windows between rodents and non-rodents
ËùÔÚ | S7 ·Ö»á±¨¸æ7
ʱ¼ä | 9ÔÂ25ÈÕ£¨ÖÜÈý£© 10:20-10:50
·Ö»áÍêÕûÒé³Ì£º
Ö÷Àíµ¥Î»£º
¹ú¼ÊÎïÀí»¯Ñ§¼ÒлᣨIAPC£©
ADMET & DMPK ¹ú¼ÊÆÚ¿¯
а쵥λ£º
±±¾©´óѧҩѧԺ
ÉϺ£½»Í¨´óѧҩѧԺ
×ðÁú¿Ê±
ÉϺ£ÌÚÂõÁªÐÂÉúÎïÊÖÒÕÓÐÏÞ¹«Ë¾
¾Û»áʱ¼ä Date£º
2024Äê9ÔÂ23-25ÈÕ
¾Û»áËùÔÚ Location£º
ÉϺ£º£Éñŵ¸»ÌØ´óÂÃ¹Ý £¨Novotel Shanghai Atiantis£©
¾Û»áÏÈÈÝ Introduction£º
https://www.iapchem.org/iapc-9
ÈçÄúÏ£ÍûÔÚÏÖ³¡Óë×ðÁú¿Ê±×¨¼ÒÅöÃæ
½Ó´ýÁªÏµ×ðÁú¿Ê±Ô¤Ô¼°²ÅÅ
ÁªÏµ×ðÁú¿Ê±
ÁªÏµÓÊÏ䣺marketing@medicilon.com.cn
×ðÁú¿Ê±µÄÁÙ´²Ç°Ò©´ú¶¯Á¦Ñ§Ð§ÀͲ¿·ÖÓµÓÐÒ»ÅúÀíÂÛ֪ʶÔúʵ¡¢ÊµÑéÂÄÀú¸»ºñµÄ¸ß¼¶×¨ÒµÈ˲ţ¬Í³Áì×ÅʵÑéÉè¼Æ¡¢ÊµÑéʵÑé¡¢ÉúÎïÆÊÎöºÍÊý¾ÝÆÊÎöµÈµÄÊÂÇé¡£
×ðÁú¿Ê±Ò©´ú¶¯Á¦Ñ§ÊµÑéÊÒÒѾͨ¹ýNMPAµÄGLPÈÏÖ¤£¬ÊµÑéÑо¿×ñÕÕICH¡¢NMPAºÍFDAµÄÖ¸µ¼ÔÔò£¬¿ÉÒÔÆ¾Ö¤¿Í»§ÐèÇóÉè¼Æ²¢¿ªÕ¹ÌåÄÚ¡¢ÌåÍâÒ©´ú¶¯Á¦Ñ§ÊÔÑ飬Ϊ¿Í»§ÌṩһÕûÌ×Ò©´ú¶¯Á¦Ñ§ÆÀ¼ÛºÍÓÅ»¯Ð§ÀÍ¡£×ðÁú¿Ê±Ò©´ú¶¯Á¦Ñ§Ð§À͸ßÖÊÁ¿µÄÊý¾Ý¡¢¸ßЧÂʵÄʵÑéÖÜÆÚ£¬Öª×ã¿Í»§´ÓÔçÆÚÒ©Îï·¢Ã÷µ½ÐÂÒ©É걨µÄÐèÇó£¬Êܵ½º£ÄÚÍâÖÚ¶à¿Í»§µÄºÃÆÀ¡£